Pipeline-Beyang Therapeutics Co., Ltd.

Pipeline

Area

Project

Indication

Administration

Region

Discovery

PCC

IND

Phase1

Phase2

Phase3

Ophthalmology

BT01001

Severe Non-Proliferative Diabetic Retinopathy (sNPDR)

Eye Drop

Global

TBD

Oncology

BY002

AML/ALL (KMT2A-r or NPM1)

Oral

Global

TBD

Metabolism

BY006

Type 1&2 Diabete (β-cell Regeneration)

Oral

Global

TBD

Address：1-3A01, 103 Cailun Rd., Shanghai 201203, China

E814, F5, 218 Sangtian St., Suzhou 215123, China
Email：liuc@beyangtx.com